UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Aluminum in Neurological and Neurodegenerative Disease

Molecular neurobiology, 2019-02, Vol.56 (2), p.1531-1538

2019

Volltextzugriff (PDF)

Retraction Note: Aluminum in Neurological and Neurodegenerative Disease

Molecular neurobiology, 2020-03, Vol.57 (3), p.1779-1779

2020

Volltextzugriff (PDF)

Run-on gene transcription in human neocortical nuclei. Inhibition by nanomolar aluminum and implications for neurodegenerative disease

Journal of molecular neuroscience, 1998-08, Vol.11 (1), p.67-78

1998

Volltextzugriff (PDF)

RETRACTED ARTICLE: Aluminum in Neurological and Neurodegenerative Disease

Molecular neurobiology, 2019-02, Vol.56 (2), p.1531-1538

2019

Volltextzugriff (PDF)

Localization of a new ferritin heavy chain sequence present in human brain mRNA to chromosome 11

Genome, 1995-06, Vol.38 (3), p.450-457

1995

Volltextzugriff (PDF)

CAN THE CONTROVERSY OF THE ROLE OF ALUMINUM IN ALZHEIMER'S DISEASE BE RESOLVED? WHAT ARE THE SUGGESTED APPROACHES TO THIS CONTROVERSY AND METHODOLOGICAL ISSUES TO BE CONSIDERED?

Journal of Toxicology and Environmental Health, Part A, 1996-08, Vol.48 (6), p.615-636

1996

Volltextzugriff (PDF)

Aluminum in Neurological Disease - a 36 Year Multicenter Study

Journal of Alzheimer's Disease and Parkinsonism, 2019, Vol.8 (6)

2019

Volltextzugriff (PDF)

Age-associated chromosome 21 loss in Down syndrome: Possible relevance to mosaicism and Alzheimer disease

American journal of medical genetics, 1993-03, Vol.45 (5), p.584-588

1993

Volltextzugriff (PDF)

A predictor for side effects in patients with Alzheimer's disease treated with deferoxamine mesylate

Clinical pharmacology and therapeutics, 1993-01, Vol.53 (1), p.30-37

1993

Volltextzugriff (PDF)

Suppression of deferoxamine mesylate treatment - induced side effects by coadministration of isoniazid in a patient with Alzheimer's disease subject to aluminum removal by ionspecific chelation

Clinical pharmacology and therapeutics, 1990-10, Vol.48 (4), p.439-446

1990

Volltextzugriff (PDF)

Issues of lead toxicity

Basic life sciences, 1990, Vol.55, p.237

1990

Volltextzugriff (PDF)

Family with 22-derived marker chromosome and late-onset dementia of the Alzheimer type: II. Further cytogenetic analysis of the marker and characterization of the high-level repeat sequences using fluorescence in situ hybridization

American journal of medical genetics, 1993-08, Vol.47 (1), p.14-19

1993

Volltextzugriff (PDF)

A de novo paradigm for male infertility

Nature communications, 2022-01, Vol.13 (1), p.154-154, Article 154

2022

Volltextzugriff (PDF)

Ligand specific effects on aluminum incorporation and toxicity in neurons and astrocytes

Brain research, 2000-09, Vol.877 (2), p.191-202

2000

Volltextzugriff (PDF)

Discontinuation of antiepileptic drugs after successful epilepsy surgery. A Canadian survey

Epilepsy research, 2012-11, Vol.102 (1), p.23-33

2012

Volltextzugriff (PDF)

MR in temporal lobe epilepsy: analysis with pathologic confirmation

American journal of neuroradiology : AJNR, 1998-01, Vol.19 (1), p.19-27

1998

Volltextzugriff (PDF)

Resolution of allelic and non-allelic variants of histone H1 by cation-exchange-hydrophilic-interaction chromatography

Journal of chromatography. B, Biomedical sciences and applications, 2000-07, Vol.744 (1), p.33-46

2000

Volltextzugriff (PDF)

Lung disease in the cystic fibrosis mouse exposed to bacterial pathogens

Nature genetics, 1995-04, Vol.9 (4), p.351-357

1995

Volltextzugriff (PDF)

Capillary electrophoresis of histone H1 variants at neutral pH in dynamically modified fused- silica tubing

Electrophoresis, 2000-07, Vol.21 (12), p.2359-2367

2000

Volltextzugriff (PDF)

Assessment of amyloid β-protein precursor gene mutations in a large set of familial and sporadic Alzheimer disease cases

American journal of human genetics, 1992-08, Vol.51 (2), p.273-282

1992

Volltextzugriff (PDF)

Alpha 1-antichymotrypsin binding to Alzheimer A beta peptides is sequence specific and induces fibril disaggregation in vitro

Journal of neurochemistry, 1993-07, Vol.61 (1), p.298-305

1993

Volltextzugriff (PDF)

Generation and characterization of novel antibodies highly selective for phosphorylated linker histone H1 in Tetrahymena and HeLa cells

Chromosoma, 1994-04, Vol.103 (2), p.111-121

1994

Volltextzugriff (PDF)

Gerstmann-Sträussler-Scheinker disease (PRNP P102L) : amyloid deposits are best recognized by antibodies directed to epitopes in PrP region 90-165

Journal of neuropathology and experimental neurology, 1995-11, Vol.54 (6), p.790-801

1995

Volltextzugriff (PDF)

Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus: correlation with calbindin-28k mRNA levels

Brain research. Molecular brain research., 1992-04, Vol.13 (3), p.239-250

1992

Volltextzugriff (PDF)

Gerstmann-Sträussler-Scheinker Disease (PRNP P102L): Amyloid Deposits Are Best Recognized by Antibodies Directed to Epitopes in PrP Region 90-165

Journal of neuropathology and experimental neurology, 1995-11, Vol.54 (6), p.790-801

1995

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(38)

Sprache

Englisch
(38)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Aluminum in Neurological and Neurodegenerative Disease

Retraction Note: Aluminum in Neurological and Neurodegenerative Disease

Run-on gene transcription in human neocortical nuclei. Inhibition by nanomolar aluminum and implications for neurodegenerative disease

RETRACTED ARTICLE: Aluminum in Neurological and Neurodegenerative Disease

Localization of a new ferritin heavy chain sequence present in human brain mRNA to chromosome 11

CAN THE CONTROVERSY OF THE ROLE OF ALUMINUM IN ALZHEIMER'S DISEASE BE RESOLVED? WHAT ARE THE SUGGESTED APPROACHES TO THIS CONTROVERSY AND METHODOLOGICAL ISSUES TO BE CONSIDERED?

Aluminum in Neurological Disease - a 36 Year Multicenter Study

Age-associated chromosome 21 loss in Down syndrome: Possible relevance to mosaicism and Alzheimer disease

A predictor for side effects in patients with Alzheimer's disease treated with deferoxamine mesylate

Suppression of deferoxamine mesylate treatment - induced side effects by coadministration of isoniazid in a patient with Alzheimer's disease subject to aluminum removal by ionspecific chelation

Issues of lead toxicity

Family with 22-derived marker chromosome and late-onset dementia of the Alzheimer type: II. Further cytogenetic analysis of the marker and characterization of the high-level repeat sequences using fluorescence in situ hybridization

A de novo paradigm for male infertility

Ligand specific effects on aluminum incorporation and toxicity in neurons and astrocytes

Discontinuation of antiepileptic drugs after successful epilepsy surgery. A Canadian survey

MR in temporal lobe epilepsy: analysis with pathologic confirmation

Resolution of allelic and non-allelic variants of histone H1 by cation-exchange-hydrophilic-interaction chromatography

Lung disease in the cystic fibrosis mouse exposed to bacterial pathogens

Capillary electrophoresis of histone H1 variants at neutral pH in dynamically modified fused- silica tubing

Assessment of amyloid β-protein precursor gene mutations in a large set of familial and sporadic Alzheimer disease cases

Alpha 1-antichymotrypsin binding to Alzheimer A beta peptides is sequence specific and induces fibril disaggregation in vitro

Generation and characterization of novel antibodies highly selective for phosphorylated linker histone H1 in Tetrahymena and HeLa cells

Gerstmann-Sträussler-Scheinker disease (PRNP P102L) : amyloid deposits are best recognized by antibodies directed to epitopes in PrP region 90-165

Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus: correlation with calbindin-28k mRNA levels

Gerstmann-Sträussler-Scheinker Disease (PRNP P102L): Amyloid Deposits Are Best Recognized by Antibodies Directed to Epitopes in PrP Region 90-165

Suchergebnisse filtern